Login / Signup

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy.

Seth J RotzNathan LuebberingBradley P DixonEugenia GkaliagkousiRobert A BrodskyChristopher E DandoySonata JodeleStella M Davies
Published in: Blood advances (2017)
Transplantation-associated thrombotic microangiopathy is associated with complement activation in vitro.This data further supports the use of eculizumab for the treatment of patients with TA-TMA.
Keyphrases
  • cell therapy
  • electronic health record
  • big data
  • machine learning
  • mesenchymal stem cells
  • combination therapy
  • data analysis